Skip to main content
Equibles
AVTR logo

AVTR · Avantor, Inc. · Metrics

Track AVTR — free

Use AVTR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AVTR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$15.05 -0.19 (-1.25%) At close · Sep 30
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$10.37B
Shares
682.76M
Volume · Sep 30 7.38M Avg daily vol (3M) 9.4M

AVTR metrics

84 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$15.05
Market cap
$10.37B

Price action

20 metrics
Price change (1W)
+2.0%
Price change (30D)
+4.8%
Price change (3M)
+53.9%
Price change (6M)
+94.4%
Price change (YTD)
+33.0%
Price change (1Y)
+28.7%
Trailing year
Price change (5Y)
-62.7%
52-week high
$15.86
52-week low
$7.41
Change from 52-week high
-3.9%
Change from 52-week low
+105.7%
Annualized volatility
51.3%
Annualized volatility (3M)
49.0%
Beta
0.9
RSI (14D)
57.2
Price vs SMA 50
+7.9%
Price vs SMA 200
+42.7%
Avg volume (3M)
9.39M
Relative volume
0.7
Average dollar volume
$124.94M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
682.76M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.1×
reciprocal yield 47.1%
EV / EBITDA
114.6×
reciprocal yield 0.9%
EV / EBIT
—
P / sales
1.6×
reciprocal yield 63.2%
P / book
1.9
reciprocal yield 53.9%
FCF yield
4.2%
TTM · current market cap
Buyback yield
—
P / FCF
23.6
reciprocal yield 4.2%
P / operating cash flow
18.1
reciprocal yield 5.5%
Earnings yield
-5.3%

Historical valuation

8 metrics
P / E historical average (3Y)
32.5×
reciprocal yield 3.1%
P / E historical average (5Y)
56.8×
reciprocal yield 1.8%
EV / revenue historical average (3Y)
2.4×
reciprocal yield 42.2%
EV / revenue historical average (5Y)
2.8×
reciprocal yield 36.3%
EV / EBIT historical average (3Y)
24.6×
reciprocal yield 4.1%
EV / EBIT historical average (5Y)
25.6×
reciprocal yield 3.9%
EV / EBITDA historical average (3Y)
25.5×
reciprocal yield 3.9%
EV / EBITDA historical average (5Y)
22.1×
reciprocal yield 4.5%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
32.1%
Operating margin
-4.5%
Trailing 12 months
Net margin
-8.4%
Gross profit (TTM)
$2.11B
Operating profit (TTM)
−$294.10M
Net income (TTM)
−$551.40M
Trailing 12 months
Diluted EPS (TTM)
$-0.81
FCF margin
6.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$8.16

Growth

11 metrics
Revenue growth YoY
+0.0%
Year over year
Net income growth YoY
-32.9%
Revenue (TTM)
$6.55B
Trailing 12 months
EPS growth YoY
-33.3%
Shares change YoY
-0.8%
Year over year · fewer shares
Revenue CAGR (3Y)
-4.5%
Revenue CAGR (5Y)
+0.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-11.3%
FCF CAGR (5Y)
-10.6%

Quality

14 metrics
Return on equity
-9.9%
Return on assets
-4.7%
Debt / equity
0.7
Current ratio
1.8
EBITDA (TTM)
$121.40M
Free cash flow (TTM)
$438.90M
Quick ratio
1.2
Interest coverage
-1.7
Net debt / EBITDA
29.1
Return on invested capital
—
Trailing 12 months
Net cash
−$3.54B
Latest balance sheet
Cash & equivalents
$279.30M
Total assets
$11.66B
Total debt
$3.82B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$573.20M
Capital expenditures (TTM)
$134.30M
R&D (TTM)
—
SG&A (TTM)
$1.61B
Stock compensation (TTM)
$42.60M
R&D / revenue
—
Stock compensation / revenue
0.7%

Ownership (13F)

3 metrics
13F filers
462
13F filer change QoQ
+29
Institutional ownership
102.5%

Short interest

3 metrics
Short interest
7.5%
Latest settlement · 6.2 days to cover
Days to cover
6.2d
Short-squeeze score
71 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1722482 CUSIP 05352A100 13F (30d) 10 filings 9 filers Visit website Investor relations